- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
44 Cards in this Set
- Front
- Back
|
What are the three classes of drugs that inhibit coagulation?
|
Anticoagulants
Fibrinolytics Anti-platelet drugs |
|
What kind of drug are heparins?
|
Anticoagulants
|
|
How are heparins administered to patients?
|
IV
Subcutaneous |
|
What is the main mechanism of heparins?
|
1. Potentiates antithrombin / serine protease (thrombin, F IXa, F Xa, F XIa) complexes
2. Irreversibly binds and inactivates factors 3. Also binds and inhibits platelets |
|
What serine proteases are especially inactivated by unfractionated heparin?
|
Thrombin
F Xa |
|
What are the clinical uses of unfractionated heparin?
|
Prevent venous thromboembolism
Cardiac bypass surgery |
|
What are the limitations of unfractionated heparin and what must be done to deal with these limitations?
|
Narrow therapeutic window
- Monitor PTT carefully Binds plasma proteins, endothelial cells, platelets - Variable dosing Monitor platelet counts regularly |
|
What are complications associated with unfractionated heparin?
|
Bleeding
Heparin-induced thrombocytopenia (HIT) |
|
What is the hematological problem seen in heparin-induced thrombocytopenia?
|
Thrombocytopenia (low platelets)
Thrombosis |
|
What causes thrombocytopenia and thrombosis in heparin-induced thrombocytopenia?
|
IgG antibodies made against the heparin + platelet factor 4 complex causing:
- Platelet aggregation - Platelet activation |
|
How is heparin-induced thrombocytopenia diagnosed?
|
Decreased platelet count
HIT assay: - Presence of antibodies against heparin + platelet factor 4 complex |
|
How is heparin-induced thrombocytopenia treated?
|
Discontinue heparin
Start thrombin inhibitor anticoagulant |
|
Which clotting factors does low molecular weight heparin (LMWH) especially inactivate?
|
F Xa > thrombin
|
|
What are the benefits of low molecular weight heparin (LMWH) over unfractioned heparin (UFH)?
|
Less platelet interaction
More predictable bioavailability and dosing Longer half life Do not need to monitor as much |
|
How is low molecular weight heparin (LMWH) administered?
|
Subcutaneously
|
|
What are the limitations of low molecular weight heparin (LMWH)?
|
Not for patients with renal failure
No antidote |
|
What are the side effects of low molecular weight heparin (LMWH)?
|
Bleeding
Bruising at injection site |
|
What patients are prescribed direct thrombin inhibitors?
|
Patients with heparin-induced thrombocytopenia
|
|
How are direct thrombin inhibitors administered?
|
IV
|
|
How are direct thrombin inhibitors monitored?
|
PTT
|
|
What patients are prescribed oral direct thrombin inhibitors?
|
Patients with atrial fibrillation
|
|
What conditions are oral direct thrombin inhibitors meant to prevent?
|
Stroke
|
|
What are the benefits of oral direct thrombin inhibitors?
|
No monitoring
Fixed dose |
|
What is the mechanism of Warfarin / Coumadin?
|
Inhibit reductase that recharges vitamin K
- Prevents activation of vitamin K-dependent factors (F II, F VII, F IX, F X) |
|
How long does Warfarin / Coumadin take to have effect?
|
3-5 days
|
|
What conditions are Warfarin / Coumadin used to treat?
|
Deep venous thrombosis
Arterial thrombosis |
|
How is Warfarin / Coumadin administered?
|
Orally
|
|
What are the limitations of Warfarin / Coumadin?
|
Multiple drug and food interactions
Narrow therapeutic window - Metabolized by liver P450 Crosses placenta - Causes birth defects |
|
How is Warfarin / Coumadin monitored?
|
INR for PT
|
|
What are side effects of Warfarin / Coumadin?
|
Bleeding
Skin necrosis |
|
What is the antidote for Warfarin / Coumadin overdose and what must be done in addition to this?
|
Vitamin K
- Takes time to work Must give with FFP |
|
What type of inhibitor of coagulation is tissue plasminogen activator (tPA)?
|
Fibrinolytic agent
|
|
How does tissue plasminogen activator (tPA) lyse clots?
|
Converts plasminogen to plasmin which effectively degrades fibrin clots
|
|
In what events is tissue plasminogen activator (tPA) used?
|
Clots in:
- Acute MI - Stroke - Large PE |
|
How is tissue plasminogen activator (tPA) administered?
|
IV
|
|
What are contraindications for tissue plasminogen activator (tPA) use?
|
GI bleeding
Neurosurgery Head injury |
|
What are the anti-platelet agents used?
|
Aspirin / Ibuprofen / Motrin
Dipyridamole Clopidogrel GPIIb / IIIa inhibitors PAR I inhibitors |
|
What are side effects of anti-platelet agents?
|
Mucosal bleeding
GI bleeding |
|
What is the treatment protocol for venous clots (DVT / PE)?
|
1. Start anticoagulants immediately:
- Low molecular weight heparin with Warfarin 2. Check INR: - If >2 for two days, stop low molecular weight heparin and continue Warfarin 3. Continue Warfarin for 3-6 months and monitor with INR |
|
What are some non-pharmaceutical treatments for deep venous thrombosis?
|
Compression stockings
Inferior vena cava filter |
|
When are inferior vena cava filteres used?
|
Patients with lower extremity deep venous thrombosis who cannot be on anticoagulants
|
|
What is the common prophylactic treatment for venous clots?
|
Low molecular weight heparin
or Unfractionated heparin |
|
What patients recieve prophylactic treatment to prevent venous clots?
|
All patients undergoing surgery
Patients under continuous bed-rest History of deep venous thrombosis |
|
What agents are used to treat arterial thromboses?
|
Tissue plasminogen activator (tPA)
- Only agent that gets rid of clot Heparins Warfarin Anti-platelet agents - For prevention |